Here is a part of our press release which was published today:
Galena Pharma has grown and invested strongly in recent years and now the growth story continues as the Finnish private equity investor Intera Partners becomes Galena Pharma’s co-owner.
“We want to grow in the international market in the coming years. The products we have developed and manufactured are already being exported to several countries and now, with the support of Intera Partners’ contacts and expertise, we can further support our internationalisation goals.” says Galena Pharma’s Managing Director Atte Kukkonen.
“Galena Pharma is a promising and successful company, and we want to support their growth. Through deep expertise and determined development, the company has become a leading player in the contract development and manufacturing (CDMO) field in Finland. With Intera’s co-ownership, Galena Pharma’s current entrepreneurs will receive even more support for internationalisation and growth,” says Arjo Laukia, a partner at Intera Partners.
Galena Pharma’s operations will continue as normal with the new co-owner, and the change will not affect the status of the company’s operational management or the personnel.